281 related articles for article (PubMed ID: 20814178)
61. Octreotide in the management of postoperative chylothorax.
Rosti L; De Battisti F; Butera G; Cirri S; Chessa M; Delogu A; Drago M; Giamberti A; Pomè G; Carminati M; Frigiola A
Pediatr Cardiol; 2005; 26(4):440-3. PubMed ID: 16374694
[TBL] [Abstract][Full Text] [Related]
62. The successful use of octreotide in the treatment of traumatic chylothorax.
Sharkey AJ; Rao JN
Tex Heart Inst J; 2012; 39(3):428-30. PubMed ID: 22719161
[TBL] [Abstract][Full Text] [Related]
63. Chest X-ray of a patient with history of pleural effusion.
Konik E; Schirger J
BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28630248
[TBL] [Abstract][Full Text] [Related]
64. [Octreotide treatment of post surgical chylothorax].
Aleo Luján E; Urán Moreno MM; Brandstrup Azuero KB; López-Herce Cid J; Zunzunegui Martínez JL
An Pediatr (Barc); 2003 Apr; 58(4):390-2. PubMed ID: 12681190
[TBL] [Abstract][Full Text] [Related]
65. Fatal pulmonary embolism complicating a postoperative chylothorax despite adequate thromboprophylaxis.
Hoskote SS; Devarapally SR; Dasgupta R; Pang Y; Shapiro JM
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):887-9. PubMed ID: 23751608
[TBL] [Abstract][Full Text] [Related]
66. [Clinical analysis of 2 cases with chylothorax due to primary lymphatic dysplasia and review of literature].
Liu J; Yao C; Xu B; Shen W; Zhou C; Duan X; Zhou J; An R; Wang W; Ding Z; Zhao S
Zhonghua Er Ke Za Zhi; 2014 May; 52(5):362-7. PubMed ID: 24969935
[TBL] [Abstract][Full Text] [Related]
67. Treatment of chylothorax in a premature infant using somatostatin.
Goto M; Kawamata K; Kitano M; Watanabe K; Chiba Y
J Perinatol; 2003 Oct; 23(7):563-4. PubMed ID: 14566354
[TBL] [Abstract][Full Text] [Related]
68. How efficacious are Octreotide and Somatostatin in the management of chylothorax in congenital cardiac surgical patients?
Madhavan S; Nakao M
Interact Cardiovasc Thorac Surg; 2021 Oct; 33(5):773-778. PubMed ID: 34000045
[TBL] [Abstract][Full Text] [Related]
69. Fibrosing mediastinitis manifesting as thoracic prevertebral thin band-like mass on MRI and PET-CT.
Lee KY; Yi JG; Park JH; Kim YJ; So Y; Kim JS
Br J Radiol; 2007 Jul; 80(955):e141-4. PubMed ID: 17704310
[TBL] [Abstract][Full Text] [Related]
70. Fibrosing mediastinitis due to Aspergillus with dominant cardiac involvement: report of two autopsy cases with review of literature.
Chatterjee D; Bal A; Singhal M; Vijayvergiya R; Das A
Cardiovasc Pathol; 2014; 23(6):354-7. PubMed ID: 24998315
[TBL] [Abstract][Full Text] [Related]
71. Somatostatin treatment of spontaneous chylothorax in an extremely low birth weight infant.
Lauterbach R; Sczaniecka B; Koziol J; Knapczyk M
Eur J Pediatr; 2005 Mar; 164(3):195-6. PubMed ID: 15611854
[No Abstract] [Full Text] [Related]
72. Successful steroid treatment for fibrosing mediastinitis and sclerosing cervicitis.
Ikeda K; Nomori H; Mori T; Kobayashi H; Iwatani K; Yoshimoto K; Yoshioka M
Ann Thorac Surg; 2007 Mar; 83(3):1199-201. PubMed ID: 17307498
[TBL] [Abstract][Full Text] [Related]
73. Octreotide therapy in two children with intractable postoperative chylothorax.
Hung WP; Wang JN; Chang HK; Wu JM
Int J Cardiol; 2011 Feb; 146(3):e63-5. PubMed ID: 19193452
[TBL] [Abstract][Full Text] [Related]
74. Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis.
Namba M; Masuda T; Nakamura T; Horimasu Y; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Intern Med; 2017 Dec; 56(24):3327-3331. PubMed ID: 29021448
[TBL] [Abstract][Full Text] [Related]
75. Prophylactic octreotide does not reduce the incidence of postoperative chylothorax following lobectomy: Results from a retrospective study.
Zhang C; Zhang H; Wu W; Liu D; Yang D; Zhang M; Lu C
Medicine (Baltimore); 2019 Jul; 98(29):e16599. PubMed ID: 31335742
[TBL] [Abstract][Full Text] [Related]
76. Multimodality Imaging of Focal and Diffuse Fibrosing Mediastinitis.
Garrana SH; Buckley JR; Rosado-de-Christenson ML; Martínez-Jiménez S; Muñoz P; Borsa JJ
Radiographics; 2019; 39(3):651-667. PubMed ID: 30951437
[TBL] [Abstract][Full Text] [Related]
77. Successful octreotide treatment of chylothorax following coronary artery bypass grafting procedure. A case report and review of the literature.
Barbetakis N; Xenikakis T; Efstathiou A; Fessatidis I
Hellenic J Cardiol; 2006; 47(2):118-22. PubMed ID: 16752533
[TBL] [Abstract][Full Text] [Related]
78. Octreotide use in post-cardiac surgery chylothorax: a 12-year perspective.
Aljazairi AS; Bhuiyan TA; Alwadai AH; Almehizia RA
Asian Cardiovasc Thorac Ann; 2017 Jan; 25(1):6-12. PubMed ID: 27920229
[TBL] [Abstract][Full Text] [Related]
79. [Chylothorax as the initial manifestation of malignant pleural mesothelioma--a case report].
Ito S; Takashima Y; Sano T; Ishikawa S; Suganuma H; Yagi T; Kobayashi J; Reshad K
Nihon Kokyuki Gakkai Zasshi; 2001 Oct; 39(10):775-80. PubMed ID: 11828734
[TBL] [Abstract][Full Text] [Related]
80. Chylothorax Associated with Chronic Lymphocytic Leukemia.
Kohmoto O; Kawabe K; Ono H; Yanagimoto R; Arimoto J; Hatada A; Suruda T; Minakata Y
Intern Med; 2016; 55(24):3641-3644. PubMed ID: 27980266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
